State Of Alaska, Department Of Revenue Nektar Therapeutics Transaction History

State Of Alaska, Department Of Revenue

$8.78 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$0.64 - $3.15 $1,388 - $6,835	-2,170 Reduced 1.66%	128,708 $90,000
Q4 2022 Jan 11, 2023	BUY	$2.03 - $4.28 $2,299 - $4,849	1,133 Added 0.87%	130,878 $295,000
Q3 2022 Oct 20, 2022	SELL	$3.04 - $5.14 $33,956 - $57,413	-11,170 Reduced 7.93%	129,745 $415,000
Q2 2022 Jul 08, 2022	BUY	$3.17 - $6.17 $39,735 - $77,340	12,535 Added 9.76%	140,915 $535,000
Q1 2022 Apr 14, 2022	SELL	$4.16 - $13.72 $9,526 - $31,418	-2,290 Reduced 1.75%	128,380 $691,000

Q4 2021 Jan 12, 2022	BUY	$10.83 - $18.41 $1.1 Million - $1.88 Million	101,898 Added 354.16%	130,670 $1.77 Million
Q3 2021 Oct 07, 2021	BUY	$13.07 - $18.84 $8,194 - $11,812	627 Added 2.23%	28,772 $516,000
Q2 2021 Jul 12, 2021	SELL	$16.52 - $20.4 $5,881 - $7,262	-356 Reduced 1.25%	28,145 $482,000
Q1 2021 Apr 09, 2021	SELL	$16.56 - $25.46 $9,969 - $15,326	-602 Reduced 2.07%	28,501 $570,000
Q4 2020 Jan 08, 2021	SELL	$15.77 - $19.03 $22,393 - $27,022	-1,420 Reduced 4.65%	29,103 $494,000
Q3 2020 Oct 05, 2020	SELL	$16.59 - $24.79 $19,161 - $28,632	-1,155 Reduced 3.65%	30,523 $506,000
Q2 2020 Jul 06, 2020	BUY	$16.86 - $23.44 $23,738 - $33,003	1,408 Added 4.65%	31,678 $733,000
Q1 2020 Apr 06, 2020	BUY	$14.47 - $27.96 $19,447 - $37,578	1,344 Added 4.65%	30,270 $540,000
Q4 2019 Jan 07, 2020	SELL	$15.87 - $23.12 $35,739 - $52,066	-2,252 Reduced 7.22%	28,926 $624,000
Q3 2019 Oct 02, 2019	SELL	$16.91 - $36.27 $173,462 - $372,057	-10,258 Reduced 24.76%	31,178 $567,000
Q2 2019 Jul 23, 2019	SELL	$31.0 - $36.3 $268,956 - $314,938	-8,676 Reduced 17.31%	41,436 $1.47 Million
Q1 2019 Apr 09, 2019	BUY	$31.58 - $46.35 $54,791 - $80,417	1,735 Added 3.59%	50,112 $1.68 Million
Q4 2018 Jan 10, 2019	BUY	$30.43 - $56.65 $83,104 - $154,711	2,731 Added 5.98%	48,377 $1.59 Million
Q3 2018 Oct 09, 2018	BUY	$46.46 - $68.49 $124,791 - $183,964	2,686 Added 6.25%	45,646 $2.78 Million
Q2 2018 Jul 10, 2018	BUY	$46.25 - $104.45 $1.67 Million - $3.77 Million	36,140 Added 529.91%	42,960 $2.1 Million
Q1 2018 Apr 19, 2018	SELL	$57.4 - $108.44 $1.41 Million - $2.66 Million	-24,555 Reduced 78.26%	6,820 $724,000
Q4 2017 Jan 19, 2018	BUY	$23.02 - $60.5 $8,977 - $23,595	390 Added 1.26%	31,375 $1.87 Million
Q3 2017 Oct 16, 2017	BUY	$17.79 - $24.0 $551,223 - $743,640	30,985	30,985 $743,000

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

Deep Track Capital, LP Greenwich, CT

18.4M
Shares

$21.5 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

12M
Shares

$14.1 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

7.57M
Shares

$8.86 Million
0.02% of portfolio
Primecap Management CO Pasadena, CA

6.97M
Shares

$8.15 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.88M
Shares

$6.88 Million
0.0% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Account